MSF demands newest COVID-19 treatment recommended by WHO must be accessible to all
Regeneron, which produces the two-drug treatment cocktail casirivimab/imdevimab, must ensure affordable pricing and adequate…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
casirivimab
Cipla to market Roche’s antibody cocktail pan-India, first batch currently available
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in…
Roche gets EUA in India for antibody cocktail (Casirivimab and Imdevimab) to treat COVID-19
Partners with Cipla for pan-India distribution
US FDA grants EUA to monoclonal antibodies from Regeneron for COVID-19 treatment
In a clinical trial, casirivimab and imdevimab, administered together, were shown to reduce COVID-19-related hospitalisation or…